Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mirjam E. van Kesteren"'
Autor:
Nicol G. M. Oonk, Lucille D. A. Dorresteijn, Eline te Braake, Kris L. L. Movig, Job van der Palen, Henk-Willem Nijmeijer, Mirjam E. van Kesteren, Christina Bode
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 15 (2024)
Background: Executing structured medication reviews (SMRs) in primary care to optimize drug treatment is considered standard care of community pharmacists in the Netherlands. Patients with Parkinson’s disease (PD) often face complex drug regimens f
Externí odkaz:
https://doaj.org/article/6a3effec03ef463f94bb250afaef2f6b
Autor:
Nicol G.M. Oonk, Kris L.L. Movig, Job van der Palen, Simone A.F. Nibourg, Kirsten Koehorst-ter Huurne, Henk-Willem Nijmeijer, Mirjam E. van Kesteren, Lucille D.A. Dorresteijn
Publikováno v:
Journal of Parkinson's disease, 12(4), 1295-1306. IOS
Background: Drug therapy is important for controlling symptoms in Parkinson’s disease (PD). However, it often results in complex medication regimens and could easily lead to drug related problems (DRP), suboptimal adherence and reduced treatment ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3629580cb281b7e74ba6399b7c0b2b62
https://doi.org/10.3233/jpd-213021
https://doi.org/10.3233/jpd-213021
Autor:
Mirjam E. van Kesteren, Kris L. L. Movig, Nicol G.M. Oonk, Henk Willem Nijmeijer, Lucille D.A. Dorresteijn, Job van der Palen
Publikováno v:
Clinical Drug Investigation, 41, 809-816. Adis International Ltd
Background and Objectives: Quality of life (QoL) in Parkinson’s disease (PD) depends on multiple factors. Due to PD treatment and accompanying, age-related or independent comorbidities, pill burden is often high. The relation of QoL and pharmacothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df156ea69b2e2eddbfc0b1a99041933a
http://www.scopus.com/inward/record.url?scp=85112172827&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85112172827&partnerID=8YFLogxK
Autor:
Harmen R. Moes, Jolien M. ten Kate, Axel T. Portman, Barbera van Harten, Mirjam E. van Kesteren, Tjeerd Mondria, Gerton Lunter, Erik Buskens, Teus van Laar
Publikováno v:
Parkinsonism and related Disorders, 109:105359. Elsevier
Background: Timely referral of Parkinson's disease (PD) patients to specialized centers for treatment with device-aided therapies (DAT) is suboptimal.Objective: To develop a screening tool for timely referral for DAT in PD and to compare the tool wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d28850d2eabe30778640adc6e019f95
https://doi.org/10.1016/j.parkreldis.2023.105359
https://doi.org/10.1016/j.parkreldis.2023.105359
Autor:
Nicol G M, Oonk, Kris L L, Movig, Job, van der Palen, Henk-Willem, Nijmeijer, Mirjam E, van Kesteren, Lucille D A, Dorresteijn
Publikováno v:
Clinical drug investigation. 41(9)
Quality of life (QoL) in Parkinson's disease (PD) depends on multiple factors. Due to PD treatment and accompanying, age-related or independent comorbidities, pill burden is often high. The relation of QoL and pharmacotherapy for comorbidities in PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8813a58c08c1d052fa0801354c22bd13
https://pubmed.ncbi.nlm.nih.gov/34374959
https://pubmed.ncbi.nlm.nih.gov/34374959